Salmeterol/Fluticasone 50/500 mcg Inhalation Powder Via Capsair vs Seretide Diskus 500 mcg Inhalation Powder in Patients With COPD
Condition(s):COPDLast Updated:May 20, 2022Terminated
Hide Studies Not Open or Pending
Condition(s):COPDLast Updated:May 20, 2022Terminated
Condition(s):AsthmaLast Updated:January 29, 2018Withdrawn
Condition(s):AsthmaLast Updated:May 29, 2018Completed
Condition(s):Allergic RhinitisLast Updated:July 12, 2021Unknown status
Condition(s):Eosinophilic Esophagitis; DysphagiaLast Updated:August 28, 2019Withdrawn
Condition(s):AsthmaLast Updated:July 11, 2018Completed
Condition(s):Rhinitis, Allergic, PerennialLast Updated:March 1, 2018Completed
Condition(s):Seasonal Allergic RhinitisLast Updated:May 18, 2018Completed
Condition(s):Percentage of Annual Acute Exacerbation; Quality of LifeLast Updated:August 6, 2012Unknown status
Condition(s):AsthmaLast Updated:October 2, 2019Completed
At TrialBulletin.com, we keep tabs on over 200,000 clinical trials in the US and abroad, using medical data supplied directly by the US National Institutes of Health. Please see the About and Contact page for details.